bullish
Mitsubishi Tanabe 1H FY18 (YE Mar'19) Results - First Glance
311 Views30 Oct 2018 16:02
Key highlights
Domestic pharma, contributing ~70% of total sales and one of the biggest victims of the ongoing pricing reforms in Japan, declined...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Mitsubishi Tanabe 1H FY18 (YE Mar'19) Results - First Glance30 Oct 2018
- Radicava Sales Uptake Key to Maintaining Flat Top-Line Over the Next 3-5 Years04 Jul 2018
- Mitsubishi Tanabe FY17 Earnings - First Glance10 May 2018
x